Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 21 Nov 2022 for Aerie Pharmaceuticals INC, €274k.
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
Jeffrey Calabrese: trading record in brief
Jeffrey Calabrese is a declared insider of Aerie Pharmaceuticals Inc, with filings sourced from SEC (Form 4). Between 1 July 2022 and 21 November 2022, the trades on record add up to 5 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
On 21 November 2022 came the latest disclosure, a transaction for €274k in Aerie Pharmaceuticals Inc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Jeffrey Calabrese
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
18,585 shares@ US$15.2597.2% of flowCommon StockSEC:0001209191-22-058160:0
179 shares@ US$15.221.0% of flowCommon StockSEC:0001209191-22-055670:0
265 shares@ US$11.571.1% of flowCommon StockSEC:0001209191-22-045975:0
266 shares@ US$8.360.8% of flowCommon StockSEC:0001209191-22-042043:0
11,276 shares0Common StockSEC:0001209191-22-041174:0
5 of 5 declarations
